Staying Updated on AML Research News: Advice from an Expert

Staying Updated on AML Research News: Advice from an Expert

/in , , , , , /by

Dr. Jeffrey Lancet, an AML expert from Moffitt Cancer Center, shares tips for sifting through research news and encourages patients to communicate with their healthcare team about what they’ve learned.

About the Guest:

Dr. Jeffrey Lancet is Chair and Program Lead in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, FL. He is nationally and internationally recognized for his clinical research in the field of acute leukemias. Learn more about Dr. Lancet, here: https://moffitt.org/research-science/researchers/jeffrey-lancet/

You might also like
What AML Patients Should Know About the COVID-19 Vaccines
Staying Updated on AML Research News: Advice from an ExpertStaying Updated on AML Research News: Advice From an Expert
What Treatments Are on the Horizon for Acute Myeloid Leukemia Patients?What Treatments Are on the Horizon for Acute Myeloid Leukemia Patients?
30-Year Acute Myeloid Leukemia Survivor Shares His JourneyUn superviviente de 30 años de leucemia mieloide aguda comparte su experiencia
New AML Therapies vs Traditional Chemotherapy: What’s the Difference?New AML Therapies vs Traditional Chemotherapy: What’s the Difference?
How Can AML Patients Benefit From Shared Decision-Making?How Can AML Patients Benefit From Shared Decision-Making?